Project
ASSESS
Aborted · 2020 until 2021
Bilz Stefan, Räss Andrea, Grillmayr Victoria
Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Aborted
Start Date
2020
End Date
2021
Financing
Industry
Brief description/objective
A randomized, double-blind, placebo-controlled, multi-Center Phase 2 study to assess the efficacy and safety of oral BAY 2327949 in patients with clinical diagnosis of chronic kidney disease due to diabetes or hypertension and at least one cardiovascular comorbidity